menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Biomarkers and Lipidology

Biomarkers and Lipidology
RestartResume
Is there a difference between biomarker cardiovascular risk assessment for broad population studies vs the role in personalized medicine? And, in i...
  • Overview

    Is there a difference between biomarker cardiovascular risk assessment for broad population studies vs the role in personalized medicine? And, in individual patients, if a difference is found between the Framingham score and the biomarker risk assessment, which is more likely to correctly predict risk? Host Dr. Alan Brown talks with Dr. Michael Davidson, director of preventive cardiology and associate vice chairman for continuing medical education at the University of Chicago, about the role of biomarkers in improving cardiovascular risk prediction and guiding treatment, compared to traditional risk factor assessment.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 12/12/19